Berkshire Hathaway (BRK.A) Weekly Outlook & Analysis – Week 42, October 2025
Ideas
Oct 13, 2025
3 Min Read
In-depth weekly analysis of Berkshire Hathaway (BRK.A) for Week 42, October 2025: price chart, technical support/resistance, MACD, volume, news impact, and actionable scenarios for traders and investors.
Welcome to the comprehensive weekly analysis of Berkshire Hathaway (NYSE:BRK.A) for Week 42, October 2025! This report provides a deep dive into the technical and fundamental landscape of BRK.A, equipping traders and investors with actionable insights for the week ahead. 📊
Summary of Latest News & Key Catalysts 📰
Major Acquisition: Berkshire Hathaway announced a $9.7B all-cash deal to acquire Occidental Petroleum’s OxyChem division on October 2, 2025, expanding its industrial and energy footprint. [Source]
Stock Performance: BRK.A closed at $734,384.96 on October 10, 2025, down 1.39% for the day but up 7.9% year-to-date. [Source]
Upcoming Earnings: The next earnings report is scheduled for November 2, 2025. Q2 2025 EPS was $7,759.58, beating consensus by $245.34. [Source]
Topic | Details |
---|---|
Latest News | $9.7B OxyChem acquisition (Oct 2, 2025) |
Stock Price (10/10) | $734,384.96, -1.39% on the day, +7.9% YTD |
Most Recent Earnings | Q2 2025 EPS $7,759.58, revenue $92.52B (Aug 2, 2025) |
TTM Metrics | Earnings $62.92B, Revenue $370.15B, Gross Profit $85.12B, Gross Margin 23% |
Analyst Outlook | Revenue up 5.2%/yr, earnings down 5.3%/yr, EPS down 3.9%/yr |
Macro Events | No major macroeconomic shocks reported in past week |
Technical Analysis 📈
Trend: Bearish – Price is below both the 10- and 50-day SMAs, with lower highs forming a clear downtrend.
Momentum: RSI at 41.95 and declining, suggesting bearish momentum and a possible approach to oversold territory.
Support Levels:
Major: $734,180 (recent swing low)
Minor: $720,000
Resistance Levels:
Major: $747,777 (50-day SMA)
Minor: $745,524 (recent support turned resistance)
Pattern: Potential descending channel; recent breach of support confirms the bearish structure.
Volume: Volume is decreasing on rallies and increasing on declines, reinforcing the bearish bias.
MACD: The MACD line remains below the signal line, confirming downside momentum.
Technical Summary Table
Indicator | Current Reading | Interpretation |
---|---|---|
Price vs. 10/50 SMA | Below | Bearish |
RSI (14) | 41.95 | Bearish, approaching oversold |
MACD | Below signal | Bearish momentum |
Volume | Up on declines, down on rallies | Bearish confirmation |
Pattern | Descending channel | Bearish structure |
Fundamental & News Impact 💼
OxyChem Acquisition: The $9.7B deal is a strategic move, expanding Berkshire’s industrial reach, but its accretive impact will take time to materialize.
Financial Health: Berkshire remains a financial powerhouse with $370B+ in annual revenue and a 17% net margin, but analyst forecasts suggest a modest revenue growth rate (5.2%/yr) and a decline in earnings (-5.3%/yr) and EPS (-3.9%/yr) in the coming years.
Market Sentiment: Despite its blue-chip status, Berkshire’s size and diversification may limit outsized returns. The stock’s recent weakness aligns with broader market caution and sector rotation.
Actionable Scenarios for the Upcoming Week 🗓️
Scenario | Trigger/Signal | Action | Key Levels |
---|---|---|---|
Bullish 🐂 | Weekly close above $748,000 | Consider long positions; watch for reversal confirmation and volume uptick | Target: $759,000+ |
Bearish 🐻 | Break below $734,000 with volume | Short/sell positions; target next support, use tight stops | Target: $720,000 |
Neutral 🤝 | Range-bound between $734,000 and $747,777 | Wait for breakout or breakdown; consider mean-reversion trades | Range: $734,000–$747,777 |
Aggressive Bearish Trade: Sell below $735,000, stop loss at $748,000, target $720,000. Rationale: continuation of downtrend.
Conservative Bearish Trade: Wait for a rally to $745,525, sell near resistance, stop loss at $750,000, target $735,000.
Bullish Reversal: Only consider long trades if price closes above $748,000 with strong volume.
Risk Management: Risk only 0.5–1% of capital per trade; use ATR(14) for stop sizing. ⚠️
Conclusion 🔍
Berkshire Hathaway (BRK.A) enters Week 42, October 2025, with a bearish technical posture and cautious fundamental outlook. The OxyChem acquisition is a major strategic event, but near-term price action is likely to be driven by technical levels and upcoming earnings. Traders should monitor key support and resistance zones, volume trends, and macro news for actionable signals.
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Please conduct your own research or consult a financial advisor before making trading decisions.

Julian Vance
Julian Vance is a quantitative strategist focused on algorithmic trading in crypto and futures. His work is dedicated to exploring how traders can leverage technology and data to gain a competitive edge.
Join our newsletter list
Sign up to get the most recent blog articles in your email every week.
More Articles